Skip to primary navigation
Skip to main content
Skip to footer

Neurotech International

ASX:NTI

Home
Corporate
Development Programs
Investors
Contact

Neurotech launches Authorised Prescriber program for its neurodevelopmental disorders therapy

3 October 2025 News & Media

Read the full article here

Footer

Suite 102 / Level 1, 55 Collins Street
Melbourne VIC 3000
Australia

moc.l1761115263anoit1761115263anret1761115263nihce1761115263torue1761115263n@ofn1761115263i1761115263

+61 (3) 9498 3132

Subscribe to our latest announcements

"*" indicates required fields

Name*

First Last

Email*

Name

This field is for validation purposes and should be left unchanged.

Copyright © 2025 Neurotech International • Site by White Noise Communications

Download prospectus